How It Works & Average Weight Loss
Weight-loss medications have gained attention for altering how the body manages appetite and energy intake. Wegovy® (Semaglutide) stands out as an FDA-approved option designed specifically for chronic weight management.
As a clinic dedicated to medical weight loss, this medication plays an important role within the non-surgical care model at Worthy Weight Loss.
Wegovy® (Semaglutide) for Medical Weight Loss
Wegovy® uses semaglutide, a medication that targets appetite regulation and food intake. The goal centers on long-term weight management rather than short-lived changes.
Our approach pairs Wegovy® with structured guidance and follow-up to help patients use the medication safely and in an informed way.
What Wegovy® Is and How Semaglutide Works in the Body
Wegovy® contains semaglutide, a GLP-1 receptor agonist. This class of medication acts like incretin hormones released after eating. These hormones communicate with the brain and digestive system to reduce hunger and promote a feeling of fullness.
Semaglutide also slows the rate at which food leaves the stomach and helps regulate blood sugar levels. Many patients notice fewer cravings and better portion control as treatment continues.
Approved Uses for Wegovy®
The FDA approved Wegovy® for chronic weight management in adults and adolescents ageds 12 and older who meet specific criteria:
Eligibility always depends on a full clinical evaluation rather than weight alone.
How Wegovy® Differs From Other GLP-1 Medications
Several GLP-1 medications use semaglutide or similar compounds. Wegovy® differs from options such as Ozempic and Rybelsus® due to its higher dosing and its specific FDA approval for weight management.
Ozempic® focuses on type 2 diabetes management, though some patients experience weight changes during treatment.
Other GLP-1 medications like Trulicity use different active ingredients and dosing schedules. These differences affect appetite control and average weight loss outcomes.
Why Wegovy® Became Widely Known for Weight Loss
Clinical trials brought Wegovy® into the spotlight. Studies such as the STEP trials showed meaningful weight reduction among participants using semaglutide alongside lifestyle changes. Media coverage and patient demand followed these results, positioning Wegovy® at the center of medical weight-loss discussions.
When Wegovy® Begins to Affect Appetite and Weight
Many patients notice changes in appetite within the first few weeks. Reduced hunger and earlier fullness often appear as the dose increases. Weight changes usually follow when appetite control becomes more consistent, often within the first 2 to 3 months.
Expected Weight Loss Outcomes With Wegovy®
Clinical data show an average reduction of about 15 percent of starting body weight over one year. Individual results vary based on dose progression, consistency, and daily habits.
The most recently approved formulation of semaglutide, Wegovy HD (7.2 mg weekly injection), has demonstrated superior weight loss efficacy compared to the Wegovy 2.4 mg dose. Recent medical trials indicate that individuals receiving the Wegovy HD 7.2 mg weekly injection achieved a mean weight loss of 18.7%.
At Worthy Weight Loss in Plano, patients using higher doses of Wegovy® alongside structured nutrition and activity plans have achieved reductions of up to 20 percent of their initial body weight.
Wegovy® Dosage and How to Use It
Wegovy® uses a once-weekly injection. Treatment begins with a low dose that gradually increases over several months. This schedule helps the body adjust and reduces unwanted effects.
At Worthy Weight Loss, patients are given straightforward guidance on how to administer injections, when to take their doses, and what steps to follow if a dose is missed—all within a comprehensive program focused on weight management, medication oversight, and overall wellness.
Insurance Coverage and Cost Considerations
Insurance coverage varies. Some plans include weight management medications, while others exclude them. During consultations, our office reviews coverage details and discusses potential out-of-pocket expenses.
Comparing Wegovy® With Other GLP-1s on Weight Loss Potential
Wegovy generally results in more significant weight loss than Ozempic or Trulicity. While all three may aid appetite control, studies indicate Wegovy is typically more effective for weight reduction.”=== Please also keep the Hyperlinks for Trulicity and Ozempic!
A Thoughtful Approach to Wegovy® at Worthy Weight Loss
Medical weight loss works best with physician oversight and individualized planning. Wegovy® fits into our broader focus on non-surgical weight loss and bariatric aftercare, guided by experience in both medical and surgical weight management.
Contact us to learn if Wegovy® fits your goals.
